News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News FDA Safety Communication Updates Stance on Endologix AAA Grafts L.A. McKeown January 13, 2022
News Daily News CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind Todd Neale January 06, 2022